SLDB

Solid Biosciences (SLDB)

Solid Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SLDB
FechaHoraFuenteTítuloSímboloCompañía
29/04/202507:00GlobeNewswire Inc.Solid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual MeetingNASDAQ:SLDBSolid Biosciences Inc
25/04/202515:05Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SLDBSolid Biosciences Inc
25/04/202515:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SLDBSolid Biosciences Inc
25/04/202515:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SLDBSolid Biosciences Inc
17/04/202517:50Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SLDBSolid Biosciences Inc
11/04/202516:03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SLDBSolid Biosciences Inc
07/04/202507:00GlobeNewswire Inc.Solid Biosciences to Participate at Upcoming Investor ConferencesNASDAQ:SLDBSolid Biosciences Inc
01/04/202507:00GlobeNewswire Inc.Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLDBSolid Biosciences Inc
01/04/202506:00GlobeNewswire Inc.Climb Bio Appoints Seasoned Biotech Leaders to Board of DirectorsNASDAQ:SLDBSolid Biosciences Inc
16/03/202523:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLDBSolid Biosciences Inc
13/03/202515:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLDBSolid Biosciences Inc
12/03/202507:00GlobeNewswire Inc.Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific ConferenceNASDAQ:SLDBSolid Biosciences Inc
06/03/202516:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SLDBSolid Biosciences Inc
06/03/202515:35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SLDBSolid Biosciences Inc
06/03/202515:16GlobeNewswire Inc.Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdatesNASDAQ:SLDBSolid Biosciences Inc
25/02/202515:05Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SLDBSolid Biosciences Inc
21/02/202517:04Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:SLDBSolid Biosciences Inc
18/02/202515:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLDBSolid Biosciences Inc
18/02/202515:47Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SLDBSolid Biosciences Inc
18/02/202515:35Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:SLDBSolid Biosciences Inc
18/02/202506:00GlobeNewswire Inc.Solid Biosciences Announces Pricing of Underwritten OfferingNASDAQ:SLDBSolid Biosciences Inc
18/02/202505:45GlobeNewswire Inc.Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003NASDAQ:SLDBSolid Biosciences Inc
14/02/202516:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SLDBSolid Biosciences Inc
21/01/202507:30GlobeNewswire Inc.Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s AtaxiaNASDAQ:SLDBSolid Biosciences Inc
15/01/202515:05GlobeNewswire Inc.Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic MedicinesNASDAQ:SLDBSolid Biosciences Inc
08/01/202515:05GlobeNewswire Inc.Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SLDBSolid Biosciences Inc
07/01/202515:15GlobeNewswire Inc.Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s AtaxiaNASDAQ:SLDBSolid Biosciences Inc
23/12/202415:05GlobeNewswire Inc.Solid Biosciences Added to the Nasdaq Biotechnology IndexNASDAQ:SLDBSolid Biosciences Inc
04/12/202407:00GlobeNewswire Inc.Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene TherapiesNASDAQ:SLDBSolid Biosciences Inc
14/11/202411:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SLDBSolid Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SLDB